Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-111811

Co-Chief Executive Officer sold 18,589 shares at $3.20 ($59,414)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Joshua B Co-Chief Executive Officer 2024-09-30 Sale −18,589 $3.20 $59,414 3,220,569 D
Open-market sales · 18,589 sh · avg $3.20 · $59,414
Loading xslF345X05/ownership.xml…